Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct;125(1):149-56.
doi: 10.1007/s11060-015-1881-3. Epub 2015 Aug 26.

Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases

Zachary A Kohutek  1 , Yoshiya Yamada  1 , Timothy A Chan  1   2 , Cameron W Brennan  2   3 , Viviane Tabar  3 , Philip H Gutin  3 , T Jonathan Yang  1 , Marc K Rosenblum  4 , Åse Ballangrud  5 , Robert J Young  6 , Zhigang Zhang  7 , Kathryn Beal  8
Affiliations

Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases

Zachary A Kohutek et al. J Neurooncol. 2015 Oct.

Abstract

Radionecrosis is a well-characterized effect of stereotactic radiosurgery (SRS) and is occasionally associated with serious neurologic sequelae. Here, we investigated the incidence of and clinical variables associated with the development of radionecrosis and related radiographic changes after SRS for brain metastases in a cohort of patients with long-term follow up. 271 brain metastases treated with single-fraction linear accelerator-based SRS were analyzed. Radionecrosis was diagnosed either pathologically or radiographically. Univariate and multivariate Cox regression was performed to determine the association between radionecrosis and clinical factors available prior to treatment planning. After median follow up of 17.2 months, radionecrosis was observed in 70 (25.8%) lesions, including 47 (17.3%) symptomatic cases. 22 of 70 cases (31.4%) were diagnosed pathologically and 48 (68.6%) were diagnosed radiographically. The actuarial incidence of radionecrosis was 5.2% at 6 months, 17.2% at 12 months and 34.0% at 24 months. On univariate analysis, radionecrosis was associated with maximum tumor diameter (HR 3.55, p < 0.001), prior whole brain radiotherapy (HR 2.21, p = 0.004), prescription dose (HR 0.56, p = 0.02) and histology other than non-small cell lung, breast or melanoma (HR 1.85, p = 0.04). On multivariate analysis, only maximum tumor diameter (HR 3.10, p < 0.001) was associated with radionecrosis risk. This data demonstrates that with close imaging follow-up, radionecrosis after single-fraction SRS for brain metastases is not uncommon. Maximum tumor diameter on pre-treatment MR imaging can provide a reliable estimate of radionecrosis risk prior to treatment planning, with the greatest risk among tumors measuring >1 cm.

Keywords: Brain; Metastasis; Necrosis; Radionecrosis; Radiosurgery; SRS.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Figures

Fig. 1
Fig. 1
Actuarial incidence of radionecrosis
Fig. 2
Fig. 2
Actuarial incidence of radionecrosis, stratified by maximum tumor diameter of ≤0.5, 0.6–1.0, 1.1–1.5, and >1.5 cm
See this image and copyright information in PMC

References

    1. Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol. 2011;29:134–141. doi: 10.1200/JCO.2010.30.1655. - DOI - PMC - PubMed
    1. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA, J Am Med Assoc. 2006;295:2483–2491. doi: 10.1001/jama.295.21.2483. - DOI - PubMed
    1. Korytko T, Radivoyevitch T, Colussi V, Wessels BW, Pillai K, Maciunas RJ, Einstein DB. 12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors. Int J Radiat Oncol Biol Phys. 2006;64:419–424. doi: 10.1016/j.ijrobp.2005.07.980. - DOI - PubMed
    1. Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, Breneman JC. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2010;77:996–1001. doi: 10.1016/j.ijrobp.2009.06.006. - DOI - PubMed
    1. Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, Bozzao A, Romano A, Enrici RM. Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol. 2011;6:48. doi: 10.1186/1748-717X-6-48. - DOI - PMC - PubMed